These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22899491)

  • 1. Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib.
    Dasanu CA; Bauer F; Codreanu I; Padmanabhan P; Rampurwala M
    Hematol Oncol; 2013 Sep; 31(3):164-6. PubMed ID: 22899491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma.
    Lipstein M; O'Connor O; Montanari F; Paoluzzi L; Bongero D; Bhagat G
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):E43-6. PubMed ID: 21856550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
    Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
    Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib in plasmablastic lymphoma: a case report and review of the literature.
    Saba NS; Dang D; Saba J; Cao C; Janbain M; Maalouf B; Safah H
    Onkologie; 2013; 36(5):287-91. PubMed ID: 23689224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
    Taddesse-Heath L; Meloni-Ehrig A; Scheerle J; Kelly JC; Jaffe ES
    Mod Pathol; 2010 Jul; 23(7):991-9. PubMed ID: 20348882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
    Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC and aggressive B-cell lymphomas.
    Slack GW; Gascoyne RD
    Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
    Lin P; Dickason TJ; Fayad LE; Lennon PA; Hu P; Garcia M; Routbort MJ; Miranda R; Wang X; Qiao W; Medeiros LJ
    Cancer; 2012 Mar; 118(6):1566-73. PubMed ID: 21882178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmablastic lymphoma affecting the lung and bone marrow with CD10 expression and t(8;14)(q24;q32) translocation.
    Chuah KL; Ng SB; Poon L; Yap WM
    Int J Surg Pathol; 2009 Apr; 17(2):163-6. PubMed ID: 18508845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib: a proteasome inhibitor with an evolving role in select subtypes of B-cell non-Hodgkin's lymphoma.
    Koprivnikar JL; Cheson BD
    Future Oncol; 2012 Apr; 8(4):359-71. PubMed ID: 22515439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraoral plasmablastic lymphoma with intravascular component and MYC translocation.
    Chapman-Fredricks J; Montague N; Akunyili I; Ikpatt O
    Ann Diagn Pathol; 2012 Jan; 16(1):48-53. PubMed ID: 21239197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
    Goy A; Younes A; McLaughlin P; Pro B; Romaguera JE; Hagemeister F; Fayad L; Dang NH; Samaniego F; Wang M; Broglio K; Samuels B; Gilles F; Sarris AH; Hart S; Trehu E; Schenkein D; Cabanillas F; Rodriguez AM
    J Clin Oncol; 2005 Feb; 23(4):667-75. PubMed ID: 15613697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases.
    Oliveira JL; Grogg KL; Macon WR; Dogan A; Feldman AL
    Am J Surg Pathol; 2012 Sep; 36(9):1364-70. PubMed ID: 22895269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood and bone marrow findings in B-cell lymphoma, unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
    Ahmad OS; Fishlock K; May P; Kanfer E; Naresh KN
    Am J Hematol; 2012 Feb; 87(2):201-2. PubMed ID: 22139902
    [No Abstract]   [Full Text] [Related]  

  • 18. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bortezomib].
    Simons S; Scheulen ME; Jaehde U
    Dtsch Med Wochenschr; 2006 Feb; 131(5):214-8. PubMed ID: 16440269
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
    Ruzinova MB; Caron T; Rodig SJ
    Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.